DE60136181D1 - 3'-prodrugs von 2'-deoxy-beta-l-nukleosiden - Google Patents

3'-prodrugs von 2'-deoxy-beta-l-nukleosiden

Info

Publication number
DE60136181D1
DE60136181D1 DE60136181T DE60136181T DE60136181D1 DE 60136181 D1 DE60136181 D1 DE 60136181D1 DE 60136181 T DE60136181 T DE 60136181T DE 60136181 T DE60136181 T DE 60136181T DE 60136181 D1 DE60136181 D1 DE 60136181D1
Authority
DE
Germany
Prior art keywords
nucleosides
deoxy
prodrugs
beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60136181T
Other languages
English (en)
Inventor
Martin L Bryant
Gilles Gosselin
Jean-Louis Imbach
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Universite Montpellier 2 Sciences et Techniques
Idenix Cayman Ltd
Original Assignee
Centre National de la Recherche Scientifique CNRS
Universite Montpellier 2 Sciences et Techniques
Idenix Cayman Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Universite Montpellier 2 Sciences et Techniques, Idenix Cayman Ltd filed Critical Centre National de la Recherche Scientifique CNRS
Application granted granted Critical
Publication of DE60136181D1 publication Critical patent/DE60136181D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60136181T 2000-06-15 2001-06-15 3'-prodrugs von 2'-deoxy-beta-l-nukleosiden Expired - Lifetime DE60136181D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21210000P 2000-06-15 2000-06-15
PCT/US2001/019147 WO2001096353A2 (en) 2000-06-15 2001-06-15 3'-PRODRUGS OF 2'-DEOXY-β-L-NUCLEOSIDES

Publications (1)

Publication Number Publication Date
DE60136181D1 true DE60136181D1 (de) 2008-11-27

Family

ID=22789563

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60136181T Expired - Lifetime DE60136181D1 (de) 2000-06-15 2001-06-15 3'-prodrugs von 2'-deoxy-beta-l-nukleosiden

Country Status (27)

Country Link
EP (1) EP1296995B1 (de)
JP (1) JP4639032B2 (de)
KR (2) KR20070048277A (de)
CN (3) CN1900104A (de)
AP (1) AP1771A (de)
AR (1) AR035711A1 (de)
AT (1) ATE411332T1 (de)
AU (2) AU2001266927B2 (de)
BR (1) BR0111732A (de)
CA (1) CA2413163C (de)
CZ (1) CZ2003122A3 (de)
DE (1) DE60136181D1 (de)
EA (1) EA005774B1 (de)
ES (1) ES2317912T3 (de)
IL (3) IL153379A0 (de)
MA (1) MA27126A1 (de)
MX (1) MXPA02012443A (de)
MY (1) MY141594A (de)
NO (1) NO20026001L (de)
NZ (2) NZ535246A (de)
OA (1) OA12384A (de)
PE (1) PE20020216A1 (de)
PL (1) PL360404A1 (de)
UY (1) UY26779A1 (de)
WO (1) WO2001096353A2 (de)
YU (1) YU94802A (de)
ZA (2) ZA200300168B (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001079246A2 (en) 2000-04-13 2001-10-25 Pharmasset, Ltd. 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of hepatitis virus infections
MY164523A (en) 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
US6787526B1 (en) 2000-05-26 2004-09-07 Idenix Pharmaceuticals, Inc. Methods of treating hepatitis delta virus infection with β-L-2′-deoxy-nucleosides
EA200601591A1 (ru) 2000-05-26 2007-02-27 Айденикс (Кайман) Лимитед Применение рибонуклеозидных соединений для лечения флавивирусных и пестивирусных инфекций
MXPA04012779A (es) * 2002-06-28 2005-08-19 Idenix Cayman Ltd Profarmacos de 2'- y 3'-nucleosido para tratar infecciones por flaviviridae.
BR0312278A (pt) * 2002-06-28 2007-06-19 Idenix Cayman Ltd éster 2'-c-metil-3'-o-l-valina de ribofuranosil citidina para tratamento de infecções por flaviviridae
US7608600B2 (en) 2002-06-28 2009-10-27 Idenix Pharmaceuticals, Inc. Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
BR0312271A (pt) 2002-06-28 2007-11-06 Idenix Cayman Ltd compostos, composições e seus usos para o tratamento de infecções por flaviviridae
BR0314259A (pt) 2002-09-13 2005-07-26 Idenix Cayman Ltd ß-l-2'-desoxinucleosìdeos para o tratamento de cepas de hbv resistentes e terapias combinadas
DK1576138T3 (en) 2002-11-15 2017-05-01 Idenix Pharmaceuticals Llc 2'-METHYL NUCLEOSIDES IN COMBINATION WITH INTERFERON AND FLAVIVIRIDAE MUTATION
CN101415719A (zh) 2003-03-20 2009-04-22 微生物化学及药品有限公司 生产2’-脱氧-β-L-核苷的方法
KR20060015542A (ko) * 2003-04-28 2006-02-17 이데닉스 (케이만) 리미티드 산업 규모의 뉴클레오시드 합성
EP2345658A1 (de) 2003-05-30 2011-07-20 Pharmasset, Inc. Modifizierte fluorinierte Nukleosidanaloga
JP2007527396A (ja) 2003-06-30 2007-09-27 イデニクス（ケイマン）リミテツド β−Ｌ−２’−デオキシヌクレオシドの合成
CN1980657A (zh) 2004-05-05 2007-06-13 耶鲁大学 新颖的抗病毒赛菊宁黄质类似物
RU2433124C2 (ru) 2004-09-14 2011-11-10 Фармассет, Инк. Способ получения 2'-фтор-2'-алкилзамещенных или других замещенных рибофуранозилпиримидинов и пуринов и их производных
US7524831B2 (en) 2005-03-02 2009-04-28 Schering Corporation Treatments for Flaviviridae virus infection
AR054778A1 (es) 2005-06-17 2007-07-18 Novartis Ag Uso de sangliferina en hcv
GB0609178D0 (en) * 2006-05-09 2006-06-21 Univ Cardiff Novel compounds
US7897737B2 (en) 2006-12-05 2011-03-01 Lasergen, Inc. 3′-OH unblocked, nucleotides and nucleosides, base modified with photocleavable, terminating groups and methods for their use in DNA sequencing
US7964580B2 (en) 2007-03-30 2011-06-21 Pharmasset, Inc. Nucleoside phosphoramidate prodrugs
TW200946541A (en) 2008-03-27 2009-11-16 Idenix Pharmaceuticals Inc Solid forms of an anti-HIV phosphoindole compound
BRPI0915173B8 (pt) 2008-06-11 2021-05-25 Agilent Technologies Inc compostos de nucleotídeos e nucleosídeos e método de sequenciamento de um ácido nucleico-alvo
AR074897A1 (es) 2008-12-23 2011-02-23 Pharmasset Inc Fosforamidatos de nucleosidos
EP2376514A2 (de) 2008-12-23 2011-10-19 Pharmasset, Inc. Nukleosidanaloga
PA8855801A1 (es) 2008-12-23 2010-07-27 Sintesis de nucleosidos de purina
TWI583692B (zh) 2009-05-20 2017-05-21 基利法瑪席特有限責任公司 核苷磷醯胺
US8618076B2 (en) 2009-05-20 2013-12-31 Gilead Pharmasset Llc Nucleoside phosphoramidates
US8859756B2 (en) 2010-03-31 2014-10-14 Gilead Pharmasset Llc Stereoselective synthesis of phosphorus containing actives
MX2012011222A (es) 2010-04-01 2013-01-18 Centre Nat Rech Scient Compuestos y composiciones farmaceuticas para el tratamiento de infecciones virales.
ES2716158T3 (es) 2010-11-30 2019-06-10 Gilead Pharmasset Llc 2'-spiro-nucleótidos para el tratamiento de hepatitis C
US9243025B2 (en) 2011-03-31 2016-01-26 Idenix Pharmaceuticals, Llc Compounds and pharmaceutical compositions for the treatment of viral infections
EP2755985B1 (de) 2011-09-12 2017-11-01 Idenix Pharmaceuticals LLC Verbindungen und zusammensetzungen zur behandlung von virusinfektionen
CN104024269B (zh) 2011-09-13 2017-05-24 激光基因公司 5‑甲氧基，3’‑oh未阻断，可快速光切割的终止核苷酸以及用于核酸测序的方法
KR101991298B1 (ko) 2011-09-16 2019-06-21 길리애드 파마셋 엘엘씨 Hcv 치료 방법
US8889159B2 (en) 2011-11-29 2014-11-18 Gilead Pharmasset Llc Compositions and methods for treating hepatitis C virus
AR090699A1 (es) * 2012-04-18 2014-12-03 Biocryst Pharm Inc Compuestos inhibidores de la actividad de la arn polimerasa viral
WO2014120981A1 (en) 2013-01-31 2014-08-07 Gilead Pharmasset Llc Combination formulation of two antiviral compounds
PL3038601T3 (pl) 2013-08-27 2020-08-24 Gilead Pharmasset Llc Formulacja złożona dwóch związków przeciwwirusowych
BR112020020804A2 (pt) * 2018-04-12 2021-01-12 Modis Therapeutics Inc. Pró-fármacos de desoxinucleosídeos para tratamento de doenças causadas por agrupamentos de nucleotídeos não balanceados

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4958013A (en) * 1989-06-06 1990-09-18 Northwestern University Cholesteryl modified oligonucleotides
IT1246983B (it) * 1990-11-13 1994-12-12 Consiglio Nazionale Ricerche L-2'-desossiuridine e composizioni farmaceutiche che le contengono.
US5559101A (en) * 1994-10-24 1996-09-24 Genencor International, Inc. L-ribofuranosyl nucleosides
SE505648C2 (sv) * 1996-08-30 1997-09-22 Scania Cv Ab Anordning vid ett fordon för monterbar anfästning av en förarplatsmodul
DK2415776T3 (en) * 1998-08-10 2016-07-04 Novartis Ag Beta-L-2'-deoxy nucleosides for the treatment of Hepatitis B

Also Published As

Publication number Publication date
WO2001096353A2 (en) 2001-12-20
NZ523632A (en) 2005-03-24
MA27126A1 (fr) 2005-01-03
IL153379A (en) 2007-02-11
ZA200300168B (en) 2004-07-07
EP1296995B1 (de) 2008-10-15
PL360404A1 (en) 2004-09-06
AP1771A (en) 2007-08-23
JP2004533403A (ja) 2004-11-04
AU6692701A (en) 2001-12-24
KR20070048277A (ko) 2007-05-08
CN1900104A (zh) 2007-01-24
OA12384A (en) 2006-04-17
NO20026001L (no) 2003-02-12
CN101012259A (zh) 2007-08-08
CZ2003122A3 (cs) 2003-06-18
UY26779A1 (es) 2001-12-28
NZ535246A (en) 2006-06-30
IL153379A0 (en) 2003-07-06
ATE411332T1 (de) 2008-10-15
EP1296995A2 (de) 2003-04-02
IL178864A0 (en) 2007-03-08
EA005774B1 (ru) 2005-06-30
EA200300023A1 (ru) 2003-08-28
BR0111732A (pt) 2003-06-24
CN1295242C (zh) 2007-01-17
AU2001266927B2 (en) 2006-12-14
MXPA02012443A (es) 2004-09-10
CA2413163C (en) 2008-11-18
NO20026001D0 (no) 2002-12-13
CN1452627A (zh) 2003-10-29
ZA200404306B (en) 2005-06-15
CA2413163A1 (en) 2001-12-20
KR20030032967A (ko) 2003-04-26
JP4639032B2 (ja) 2011-02-23
ES2317912T3 (es) 2009-05-01
PE20020216A1 (es) 2002-04-16
AR035711A1 (es) 2004-07-07
MY141594A (en) 2010-05-14
YU94802A (sh) 2006-03-03
AP2003002713A0 (en) 2003-03-31
WO2001096353A3 (en) 2002-04-18

Similar Documents

Publication Publication Date Title
DE60136181D1 (de) 3'-prodrugs von 2'-deoxy-beta-l-nukleosiden
NO20031268D0 (no) 4-aminokinazoliner
CY2012029I2 (el) Nεα μορφη της 5-ομεπραζολης
DE69928195D1 (de) Komplettierung von Untrerdruck-Bohrlöchern
CY2006003I2 (el) Χρηση δαπτομυκινης
ID30590A (id) Celana sekali pakai jenis-celana pendek
ID30187A (id) Dongkrak jenis pantagraf
DE60126814D1 (de) Inhalation von stickoxid
DE60132362D1 (de) Herstellung von ultradünnwandigen cordierit-strukturen
DE60142051D1 (de) Herstellung von perfluorolefinen
ATE259825T1 (de) Hemihydrat von 16.alpha.-bromoepiandrosterone
NO20031267D0 (no) 4-aminokinazoliner
ID28032A (id) TRISIKLIK PIPERIDIN-Δ3-SEBAGAI ANTAGONIS-α2
DE60007360T2 (de) Amorphe modifikation von torasemid
DE60031450D1 (de) Polymorph v von torasemid
ID30381A (id) Penggunaan arilalkanoilpiridazina
DE60207900D1 (de) "Suspend"-Paketübertrager
ITRC20000004V0 (it) Deodorante - souvenir "i calandreddhi"
ITRC20010003A1 (it) "fumanello"
PT9613T (pt) Vysor 3 d
UA4579S (uk) Дозиметр-радіометр гамма-бета-випромінювань
SE0002629D0 (sv) Novel compounds and their use
ITSA20000021A0 (it) Eufrasia 2000
UA3680S (uk) Гітара "інтеркрасстер"
ES1047290Y (es) "envase"

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R082 Change of representative

Ref document number: 1296995

Country of ref document: EP

Representative=s name: JONES DAY RECHTSANWAELTE PATENTANWAELTE, DE